A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours

Laura Horsley, Jeff Cummings, Mark Middleton, Tim Ward, Alison Backen, Andrew Clamp, Martin Dawson, Hayley Farmer, Nita Fisher, Gavin Halbert, Sarah Halford, Adrian Harris, Jurjees Hasan, Philip Hogg, Gireesh Kumaran, Ross Little, Geoff J. M. Parker, Paula Potter, Mark Saunders, Caleb RobertsDanielle Shaw, Nigel Smith, Jon Smythe, Andrew Taylor, Helen Turner, Yvonne Watson, Caroline Dive, Gordon C. Jayson, Cancer Research UK Drug Development Office Phase I clinical trial

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A phase 1 trial of intravenous 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide (GSAO) in patients with advanced solid tumours'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science